Results 101 to 110 of about 10,819,007 (349)

A NEW OUTCOME MEASURE FOR COST-UTILITY ANALYSES OF SCREENING PROGRAMS [PDF]

open access: yes
In this paper we provide a new outcome measure for the cost-utility analyses of alternative screening programs of a particular disease. We show that for non-invasive screening programs satisfying plausible assumptions, QALYs can be replaced by a simpler ...
Carmen Herrero Blanco   +1 more
core  

Predictors of 6 Month Health Utility Outcomes in Survivors of Acute Respiratory Distress Syndrome

open access: yesThorax, 2016
Background With improving short-term mortality in acute respiratory distress syndrome (ARDS), understanding and improving quality of life (QOL) outcomes in ARDS survivors is a clinical and research priority.
Samuel M. Brown   +7 more
semanticscholar   +1 more source

Claudin‐6 Protein Expression in Atypical Teratoid/Rhabdoid Tumors Is Strongly Enriched in the Molecular Subgroup AT/RT‐TYR

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Claudin‐6 has emerged as a promising immunotherapeutic target, yet protein‐level data in atypical teratoid/rhabdoid tumors (AT/RTs) have been inconsistent. We analyzed 36 well‐characterized AT/RT samples and found membranous claudin‐6 protein expression in 58% of cases, with striking enrichment in the molecular subgroup AT/RT‐TYR (100%) and ...
Victoria E. Fincke   +4 more
wiley   +1 more source

EQ-5D™-derived utility values for different levels of migraine severity from a UK sample of migraineurs

open access: yesHealth and Quality of Life Outcomes, 2012
Background To estimate utility values for different levels of migraine pain severity from a United Kingdom (UK) sample of migraineurs. Methods One hundred and six migraineurs completed the EQ-5D to evaluate their health status for mild, moderate and ...
Stafford Megan R   +5 more
doaj   +1 more source

The Design of Pension Pay Out Options when the Health Status during Retirement is Uncertain [PDF]

open access: yes
This paper examines the optimal design of pension plans when the health status during retirement is uncertain. Assuming that the health status affects both life expectancy and the marginal utility of consumption, choice between a lump-sum payment and an ...
Mathias Kifmann
core  

Current Approaches to Improving the Value of Care: A Physician's Perspective [PDF]

open access: yes, 2007
Evaluates the utility of judgment-based approaches to quality improvement -- pay-for-performance, public reporting, consumer-directed health plans, and tiering -- as ways to control costs.
Howard B. Beckman   +2 more
core  

A structured review of health utility measures and elicitation in advanced/metastatic breast cancer

open access: yesClinicoEconomics and Outcomes Research, 2016
Background Health utilities are increasingly incorporated in health economic evaluations. Different elicitation methods, direct and indirect, have been established in the past.
Y. Hao, V. Wolfram, J. Cook
semanticscholar   +1 more source

Time Toxicity in Wilms Tumor: Quantifying the Burden of Healthcare Interaction in the First Year After Diagnosis

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Wilms tumor (WT) treatment imposes a significant time burden on patients and their families. Time toxicity is a patient‐centered metric that quantifies the burden of healthcare interaction. We sought to define time toxicity in the first year after diagnosis of WT and hypothesized that it would increase as tumor stage and treatment ...
Caleb Q. Ashbrook   +6 more
wiley   +1 more source

Deploying projected utility to predict health behaviour in health economics: a quantitative study

open access: yesScientific Reports
Expected utility is increasingly deployed as a predictor of health behaviour within the broader domain of health economics and health sciences in general. However, research shows that this concept only explains limited variance in health behaviour.
Damien S. E. Broekharst   +4 more
doaj   +1 more source

Health Utility Book (HUB)–Cancer: Protocol for a Systematic Literature Review of Health State Utility Values in Cancer

open access: yesMDM Policy & Practice, 2019
Background. Treatment options in oncology are rapidly advancing, and public payer systems are increasingly under pressure to adopt new but expensive cancer treatments.
Michael James Zoratti   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy